206 related articles for article (PubMed ID: 31288998)
1. The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships.
Bresee JS; Lafond KE; McCarron M; Azziz-Baumgartner E; Chu SY; Ebama M; Hinman AR; Xeuatvongsa A; Bino S; Richardson D; Porter RM; Moen A; McKinlay M;
Vaccine; 2019 Aug; 37(35):5089-5095. PubMed ID: 31288998
[TBL] [Abstract][Full Text] [Related]
2. Supporting national immunization technical advisory groups (NITAGs) in resource-constrained settings. New strategies and lessons learned from the Task Force for Global Health's Partnership for influenza vaccine introduction.
Ba-Nguz A; Shah A; Bresee JS; Lafond KE; Cavallaro K; Shefer A; Donadel M; Seward JF
Vaccine; 2019 Jun; 37(28):3646-3653. PubMed ID: 31130258
[TBL] [Abstract][Full Text] [Related]
3. Ancillary benefits of seasonal influenza vaccination in middle-income countries.
Ebama MS; Chu SY; Azziz-Baumgartner E; Lafond KE; McCarron M; Hadler SC; Porter RM; McKinlay M; Bresee J
Vaccine; 2021 Apr; 39(14):1892-1896. PubMed ID: 33714656
[TBL] [Abstract][Full Text] [Related]
4. Developing a seasonal influenza vaccine recommendation in Kenya: Process and challenges faced by the National Immunization Technical Advisory Group (NITAG).
Dawa J; Chaves SS; Ba Nguz A; Kalani R; Anyango E; Mutie D; Muthoka P; Tabu C; Maritim M; Amukoye E; Were F;
Vaccine; 2019 Jan; 37(3):464-472. PubMed ID: 30502070
[TBL] [Abstract][Full Text] [Related]
5. Value and effectiveness of National Immunization Technical Advisory Groups in low- and middle-income countries: a qualitative study of global and national perspectives.
Bell S; Blanchard L; Walls H; Mounier-Jack S; Howard N
Health Policy Plan; 2019 May; 34(4):271-281. PubMed ID: 31074778
[TBL] [Abstract][Full Text] [Related]
6. Program cost analysis of influenza vaccination of health care workers in Albania.
Pallas SW; Ahmeti A; Morgan W; Preza I; Nelaj E; Ebama M; Levin A; Lafond KE; Bino S
Vaccine; 2020 Jan; 38(2):220-227. PubMed ID: 31669063
[TBL] [Abstract][Full Text] [Related]
7. Progress toward sustainable influenza vaccination in the Lao Peoples' Democratic Republic, 2012-2018.
Xeuatvongsa A; Mott JA; Khanthamaly V; Patthammavong C; Phounphenghak K; McKinlay M; Mirza S; Lafond KE; McCarron M; Corwin A; Moen A; Olsen SJ; Bresee JS
Vaccine; 2019 May; 37(23):3002-3005. PubMed ID: 31027926
[TBL] [Abstract][Full Text] [Related]
8. Seasonal influenza vaccination in middle-income countries: Assessment of immunization practices in Belarus, Morocco, and Thailand.
Mantel C; Chu SY; Hyde TB; Lambach P;
Vaccine; 2020 Jan; 38(2):212-219. PubMed ID: 31699507
[TBL] [Abstract][Full Text] [Related]
9. Influenza vaccine programs for children in low- and middle-income countries: current status and way forward.
Ortiz JR; Neuzil KM
Expert Rev Vaccines; 2019 Jul; 18(7):711-724. PubMed ID: 31226895
[No Abstract] [Full Text] [Related]
10. Strengthening vaccination policies in Latin America: an evidence-based approach.
Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
[TBL] [Abstract][Full Text] [Related]
11. Barriers and activities to implementing or expanding influenza vaccination programs in low- and middle-income countries: A global survey.
Kraigsley AM; Moore KA; Bolster A; Peters M; Richardson D; Arpey M; Sonnenberger M; McCarron M; Lambach P; Maltezou HC; Bresee JS
Vaccine; 2021 Jun; 39(25):3419-3427. PubMed ID: 33992439
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the impact of immunization policies, including the addition of pharmacists as immunizers, on influenza vaccination coverage in Nova Scotia, Canada: 2006 to 2016.
Isenor JE; O'Reilly BA; Bowles SK
BMC Public Health; 2018 Jun; 18(1):787. PubMed ID: 29940903
[TBL] [Abstract][Full Text] [Related]
13. A global review of national influenza immunization policies: Analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization.
Ortiz JR; Perut M; Dumolard L; Wijesinghe PR; Jorgensen P; Ropero AM; Danovaro-Holliday MC; Heffelfinger JD; Tevi-Benissan C; Teleb NA; Lambach P; Hombach J
Vaccine; 2016 Oct; 34(45):5400-5405. PubMed ID: 27646030
[TBL] [Abstract][Full Text] [Related]
14. Supporting countries in establishing and strengthening NITAGs: lessons learned from 5 years of the SIVAC initiative.
Adjagba A; Senouci K; Biellik R; Batmunkh N; Faye PC; Durupt A; Gessner BD; da Silva A
Vaccine; 2015 Jan; 33(5):588-95. PubMed ID: 25545597
[TBL] [Abstract][Full Text] [Related]
15. Strengthening national vaccine decision-making: Assessing the impact of SIVAC Initiative support on national immunisation technical advisory group (NITAG) functionality in 77 low and middle-income countries.
van Zandvoort K; Howard N; Mounier-Jack S; Jit M
Vaccine; 2019 Jan; 37(3):430-434. PubMed ID: 30545715
[TBL] [Abstract][Full Text] [Related]
16. Progress in the establishment and strengthening of national immunization technical advisory groups: analysis from the 2013 WHO/UNICEF joint reporting form, data for 2012.
Duclos P; Dumolard L; Abeysinghe N; Adjagba A; Janusz CB; Mihigo R; Mosina L; Takashima Y; Oztürk MH
Vaccine; 2013 Nov; 31(46):5314-20. PubMed ID: 24055304
[TBL] [Abstract][Full Text] [Related]
17. Data and product needs for influenza immunization programs in low- and middle-income countries: Rationale and main conclusions of the WHO preferred product characteristics for next-generation influenza vaccines.
Neuzil KM; Bresee JS; de la Hoz F; Johansen K; Karron RA; Krishnan A; Madhi SA; Mangtani P; Spiro DJ; Ortiz JR;
Vaccine; 2017 Oct; 35(43):5734-5737. PubMed ID: 28893473
[TBL] [Abstract][Full Text] [Related]
18. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.
Blau J; Hoestlandt C; D Clark A; Baxter L; Felix Garcia AG; Mounaud B; Mosina L
Vaccine; 2015 May; 33 Suppl 1():A34-9. PubMed ID: 25919171
[TBL] [Abstract][Full Text] [Related]
19. Influenza vaccination in the Americas: Progress and challenges after the 2009 A(H1N1) influenza pandemic.
Ropero-Álvarez AM; El Omeiri N; Kurtis HJ; Danovaro-Holliday MC; Ruiz-Matus C
Hum Vaccin Immunother; 2016 Aug; 12(8):2206-2214. PubMed ID: 27196006
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: a systematic review and meta-analysis.
Breteler JK; Tam JS; Jit M; Ket JC; De Boer MR
Vaccine; 2013 Oct; 31(45):5168-77. PubMed ID: 24012574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
